FFCP PHASE1:Hg19::chr22:22400945..22400954,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=strong | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr22:22400945..22400954,- | |||
|coexpression_cluster_id=C62 | |||
|description=CAGE_peak_at_chr22:22400945..22400954,- | |||
|id=chr22:22400945..22400954,- | |||
|ontology_enrichment_celltype=CL:0000945!1.26e-54!24;CL:0000826!1.26e-54!24;CL:0000542!1.20e-28!53;CL:0000051!1.20e-28!53;CL:0000838!1.76e-24!52;CL:0000236!5.02e-20!14;CL:0000819!8.85e-13!1;CL:0002087!9.96e-12!119;CL:0000738!1.54e-11!140;CL:0002032!1.63e-09!165;CL:0000837!1.63e-09!165;CL:0002031!2.67e-09!124;CL:0000037!4.74e-09!172;CL:0000566!4.74e-09!172;CL:0000988!1.89e-08!182;CL:0000785!5.11e-07!2;CL:0000955!5.11e-07!2;CL:0000818!5.11e-07!2;CL:0000954!5.11e-07!2;CL:0000816!5.11e-07!2 | |||
|ontology_enrichment_celltype_v019=CL:0000785;4.66e-66;1!CL:0000819;4.66e-66;1!CL:0000945;1.16e-25;24!CL:0000542;1.87e-11;53 | |||
|ontology_enrichment_celltype_v019_2=CL:0000819,4.66e-66,1;CL:0000785,7.05e-34,2;CL:0000955,7.05e-34,2;CL:0000818,7.05e-34,2;CL:0000954,7.05e-34,2;CL:0000816,7.05e-34,2;CL:0000945,1.16e-25,24;CL:0000826,1.16e-25,24;CL:0000817,4.09e-23,3;CL:0000838,1.77e-12,52;CL:0000542,2.91e-12,53;CL:0000051,2.91e-12,53 | |||
|ontology_enrichment_development_v019=CL:0000954;7.05e-34;2!CL:0000051;1.87e-11;53 | |||
|ontology_enrichment_disease=DOID:0060058!1.61e-18!10;DOID:0060073!8.85e-13!1;DOID:8675!8.85e-13!1;DOID:12603!1.57e-12!1 | |||
|ontology_enrichment_disease_v019=DOID:0060073;4.66e-66;1!DOID:8675;4.66e-66;1!DOID:0060058;1.10e-59;10!DOID:2531;5.38e-09;51!DOID:0060083;5.38e-09;51 | |||
|ontology_enrichment_disease_v019_2=DOID:0060073,4.66e-66,1;DOID:8675,4.66e-66,1;DOID:0060058,1.10e-59,10;DOID:2531,1.06e-12,51;DOID:0060083,1.06e-12,51 | |||
|ontology_enrichment_uberon=UBERON:0001154!1.75e-12!1;UBERON:0001153!1.75e-12!1;UBERON:0002372!4.81e-12!1;UBERON:0001961!4.81e-12!1;UBERON:0001744!4.81e-12!1;UBERON:0001735!4.81e-12!1 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.305653622991805,0.328402357799783,0.472264687882075,0,0.383829398097213,0,0,0,0,3.09868802321207,2.13253848731132,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.546138611262131,0,0,0,0.574752439954483,0,0.954053754535364,0,0.587237189370939,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.100528972411631,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.507447609232169,0,0,0,0,0,0,0,0,0,0,0.557409525377156,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.552567831062295,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.82454789215666,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.171594997861965,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.60896299190448,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0673520530145875,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr22:22400945..22400954,- | |||
}} |
Latest revision as of 19:23, 28 July 2015
Short description: | p@chr22:22400945..22400954, - |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr22:22400945..22400954, - |
Coexpression cluster: | C62_Burkitt_tonsil_CD19_submaxillary_spleen_salivary_lymph |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
B-1 B cell | 4.66e-66 | 1 |
mature B cell | 7.05e-34 | 2 |
pre-B-II cell | 7.05e-34 | 2 |
transitional stage B cell | 7.05e-34 | 2 |
small pre-B-II cell | 7.05e-34 | 2 |
immature B cell | 7.05e-34 | 2 |
lymphocyte of B lineage | 1.16e-25 | 24 |
pro-B cell | 1.16e-25 | 24 |
precursor B cell | 4.09e-23 | 3 |
lymphoid lineage restricted progenitor cell | 1.77e-12 | 52 |
lymphocyte | 2.91e-12 | 53 |
common lymphoid progenitor | 2.91e-12 | 53 |
Ontology term | p-value | n |
---|---|---|
lymphatic system cancer | 4.66e-66 | 1 |
lymphosarcoma | 4.66e-66 | 1 |
lymphoma | 1.10e-59 | 10 |
hematologic cancer | 1.06e-12 | 51 |
immune system cancer | 1.06e-12 | 51 |